Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

110 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Consensus-Derived Quality Performance Indicators for Neuroendocrine Tumour Care.
Woodhouse B, Pattison S, Segelov E, Singh S, Parker K, Kong G, Macdonald W, Wyld D, Meyer-Rochow G, Pavlakis N, Conroy S, Gordon V, Koea J, Kramer N, Michael M, Wakelin K, Asif T, Lo D, Price T, Lawrence B; Commonwealth Neuroendocrine Tumour Collaboration (CommNETs). Woodhouse B, et al. Among authors: pattison s. J Clin Med. 2019 Sep 12;8(9):1455. doi: 10.3390/jcm8091455. J Clin Med. 2019. PMID: 31547431 Free PMC article.
Pituitary function following peptide receptor radionuclide therapy for neuroendocrine tumours.
Elston MS, Love A, Kevat D, Carroll R, Siow ZR, Pattison S, Boyle V, Segelov E, Strickland AH, Wyld D, Gauci R, Kennedy K, Ransom D; Commonwealth Neuroendocrine Tumour Collaboration (CommNETs). Elston MS, et al. Among authors: pattison s. Cancer Med. 2021 Dec;10(23):8405-8411. doi: 10.1002/cam4.4345. Epub 2021 Oct 26. Cancer Med. 2021. PMID: 34697905 Free PMC article.
Impact of first-line FOLFIRINOX versus Gemcitabine/Nab-Paclitaxel chemotherapy on survival in advanced pancreatic cancer: Evidence from the prospective international multicentre PURPLE pancreatic cancer registry.
Santucci J, Tacey M, Thomson B, Michael M, Wong R, Shapiro J, Jennens R, Clarke K, Pattison S, Burge M, Zielinski R, Nikfarjam M, Ananda S, Lipton L, Gibbs P, Lee B. Santucci J, et al. Among authors: pattison s. Eur J Cancer. 2022 Oct;174:102-112. doi: 10.1016/j.ejca.2022.06.042. Epub 2022 Aug 18. Eur J Cancer. 2022. PMID: 35988408
Early onset pancreatic cancer-exploring contemporary treatment and outcomes using real-world data.
Mendis S, Lipton L, To YH, Ananda S, Michael M, McLachlan SA, Thomson B, Loveday B, Knowles B, Fox A, Nikfarjam M, Usatoff V, Shapiro J, Clarke K, Pattison S, Chee CE, Zielinski R, Wong R, Gibbs P, Lee B. Mendis S, et al. Among authors: pattison s. Br J Cancer. 2024 May;130(9):1477-1484. doi: 10.1038/s41416-024-02619-5. Epub 2024 Mar 6. Br J Cancer. 2024. PMID: 38448752
Bespoke treatment: drivers beware!
Pattison S, Zalcberg JR. Pattison S, et al. Asia Pac J Clin Oncol. 2014 Dec;10(4):378-80. doi: 10.1111/ajco.12265. Epub 2014 Aug 25. Asia Pac J Clin Oncol. 2014. PMID: 25155963
The Epigenetic landscape of Circulating tumour cells.
Vasantharajan SS, Eccles MR, Rodger EJ, Pattison S, McCall JL, Gray ES, Calapre L, Chatterjee A. Vasantharajan SS, et al. Among authors: pattison s. Biochim Biophys Acta Rev Cancer. 2021 Apr;1875(2):188514. doi: 10.1016/j.bbcan.2021.188514. Epub 2021 Jan 23. Biochim Biophys Acta Rev Cancer. 2021. PMID: 33497709 Review.
Use and outcomes from neoadjuvant chemotherapy in borderline resectable pancreatic ductal adenocarcinoma in an Australasian population.
Walpole I, Lee B, Shapiro J, Thomson B, Lipton L, Ananda S, Usatoff V, Mclachlan SA, Knowles B, Fox A, Wong R, Cooray P, Burge M, Clarke K, Pattison S, Nikfarjam M, Tebbutt N, Harris M, Nagrial A, Zielinski R, Chee CE, Gibbs P. Walpole I, et al. Among authors: pattison s. Asia Pac J Clin Oncol. 2023 Feb;19(1):214-225. doi: 10.1111/ajco.13807. Epub 2022 Jul 13. Asia Pac J Clin Oncol. 2023. PMID: 35831999
110 results